v3.26.1
Segment and Geographic Information (Tables)
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of segment profit or loss, including significant segment expenses
The table below is a summary of the segment profit or loss, including significant segment expenses (in thousands):
Three months ended March 31,
20262025
Net product revenue - U.S.$36,896 $24,369 
Net product revenue - International23,216 13,349 
Total net product revenue 60,112 37,718 
License revenue- (5,014)
Total revenue, net 60,112 32,704 
Cost of sales7,157 3,648 
Global headcount expense 58,653 34,868 
Preclinical, clinical and development expense 18,511 19,960 
Commercial & medical affairs 20,264 13,249 
Corporate, general & administrative 7,888 7,983 
Other income (expense), net(1,704)(644)
Interest income (expense), net(1,029)(1,770)
Income taxes 545 80 
Net loss $(55,639)$(49,498)
Schedule of revenue by geographic area
The Company allocates, for the purpose of geographic data reporting, its revenue based upon the location of its customers. Total product revenue, net, by geographic area was as follows (in thousands):
Three months ended March 31,
20262025
US $36,896 $24,369 
International23,216 13,349 
Total product revenue, net$60,112 $37,718